Influence of glutoxim and its derivatives on the growth of mycobacterium tuberculosis (Mtb)

O. Manicheva, N. Solovyeva, M. Dogonadze, N. Melnikova, V. Zhuravlev, A. Zmaznova (Saint-Petersburg, Russian Federation)

Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session: Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Session type: Thematic Poster Session
Number: 2641
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Manicheva, N. Solovyeva, M. Dogonadze, N. Melnikova, V. Zhuravlev, A. Zmaznova (Saint-Petersburg, Russian Federation). Influence of glutoxim and its derivatives on the growth of mycobacterium tuberculosis (Mtb). Eur Respir J 2014; 44: Suppl. 58, 2641

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Minimal inhibiting concentration of cationic surfactants against various genotypes of mycobacterium tuberculosis (MBT)
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Biological properties of Mycobacterium tuberculosis (Mtb) resistant to biocides
Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis
Year: 2021


Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015

Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Can M. smegmatis be used as a real alternative for M. tuberculosis?
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016


On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004



Properties of cultures of M. tuberculosis isolated from the surfaces of objects TB facilities
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013


Comparision of line probe assay and conventional methos for detection of mycobacteria other than tuberculosis (MOTT) strains from patients suferring from pulmonary tuberculosis
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017

Rapid detection of mycobacterial growth in in vitro cultures by VOC analysis
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Pathogenicity of NTM: new developments
Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge
Year: 2007


Development of a prognostic scoring system for Mycobacterium avium complex lung disease
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


Microbiology of Mycobacterium tuberculosis and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012


Survival of mycobacterium tuberculosis (MBT) on model surfaces
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012

Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015

Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001

The WHO strategy for TB control and elimination
Source: Eur Respir Mon 2012; 58: 242-253
Year: 2012


Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012)
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013